Hotta K - Search Results

1

Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial.

Goldman JW, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin D, Statsenko G, Hochmair MJ, Özgüroğlu M, Ji JH, Garassino MC, Voitko O, Poltoratskiy A, Ponce S, Verderame F, Havel L, Bondarenko I, Każarnowicz A, Losonczy G, Conev NV, Armstrong J, Byrne N, Thiyagarajah P, Jiang H, Paz-Ares L; CASPIAN investigators. Goldman JW, et al. Among authors: hotta k. Lancet Oncol. 2021 Jan;22(1):51-65. doi: 10.1016/S1470-2045(20)30539-8. Epub 2020 Dec 4. Lancet Oncol. 2021. PMID: 33285097 Clinical Trial.

2

Phase I/II study of 3-week cycle cisplatin-gemcitabine in advanced non-small cell lung cancer.

Kusaba H, Tamura T, Shimoyama T, Hotta K, Inoue A, Nokihara H, Ueda Y, Akiyama Y, Yamamoto N, Sekine I, Kunitoh H, Ohe Y, Kodama T, Saijo N. Kusaba H, et al. Among authors: hotta k. Jpn J Clin Oncol. 2002 Feb;32(2):43-7. doi: 10.1093/jjco/hyf013. Jpn J Clin Oncol. 2002. PMID: 11948227 Clinical Trial.

3

Study of paclitaxel and dose escalation of cisplatin in patients with advanced non-small cell lung cancer.

Watanabe H, Yamamoto N, Tamura T, Shimoyama T, Hotta K, Inoue A, Sawada M, Akiyama Y, Kusaba H, Nokihara H, Sekine I, Kunitoh H, Ohe Y, Kodama T, Saijo N. Watanabe H, et al. Among authors: hotta k. Jpn J Clin Oncol. 2003 Dec;33(12):626-30. doi: 10.1093/jjco/hyg116. Jpn J Clin Oncol. 2003. PMID: 14769840

4

A phase I study and pharmacokinetics of irinotecan (CPT-11) and paclitaxel in patients with advanced non-small cell lung cancer.

Hotta K, Ueoka H, Kiura K, Tabata M, Kuyama S, Satoh K, Kozuki T, Hisamoto A, Hosokawa S, Fujiwara K, Tanimoto M. Hotta K, et al. Lung Cancer. 2004 Jul;45(1):77-84. doi: 10.1016/j.lungcan.2004.01.001. Lung Cancer. 2004. PMID: 15196737 Clinical Trial.

5

Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: reappraisal with a meta-analysis of randomized controlled trials.

Hotta K, Matsuo K, Ueoka H, Kiura K, Tabata M, Tanimoto M. Hotta K, et al. J Clin Oncol. 2004 Oct 1;22(19):3860-7. doi: 10.1200/JCO.2004.01.153. Epub 2004 Aug 23. J Clin Oncol. 2004. PMID: 15326194

6

Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer.

Hotta K, Matsuo K, Ueoka H, Kiura K, Tabata M, Tanimoto M. Hotta K, et al. J Clin Oncol. 2004 Oct 1;22(19):3852-9. doi: 10.1200/JCO.2004.02.109. Epub 2004 Aug 23. J Clin Oncol. 2004. PMID: 15326195

7

Phase I study of irinotecan and amrubicin in patients with advanced non-small-cell lung cancer.

Hotta K, Takigawa N, Kiura K, Tabata M, Umemura S, Ogino A, Uchida A, Bessho A, Segawa Y, Shinkai T, Nogami N, Harita S, Okimoto N, Ueoka H, Tanimoto M. Hotta K, et al. Anticancer Res. 2005 May-Jun;25(3c):2429-34. Anticancer Res. 2005. PMID: 16080470 Free article. Clinical Trial.

8

A phase I study of 3-day topotecan and cisplatin in elderly patients with small-cell lung cancer.

Fujiwara K, Ueoka H, Kiura K, Tabata M, Takigawa N, Hotta K, Umemura S, Sugimoto K, Shibayama T, Kamei H, Harita S, Okimoto N, Tanimoto M. Fujiwara K, et al. Among authors: hotta k. Cancer Chemother Pharmacol. 2006 Jun;57(6):755-60. doi: 10.1007/s00280-005-0117-1. Epub 2005 Oct 6. Cancer Chemother Pharmacol. 2006. PMID: 16208519 Clinical Trial.

9

Safety and efficacy of gefitinib treatment in elderly patients with non-small-cell lung cancer: Okayama Lung Cancer Study Group experience.

Hotta K, Ueoka H, Kiura K, Tabata M, Ogino A, Umemura S, Harita S, Gemba K, Yonei T, Bessho A, Maeda T, Tanimoto M. Hotta K, et al. Acta Oncol. 2005;44(7):717-22. doi: 10.1080/02841860500256215. Acta Oncol. 2005. PMID: 16227162

10

Systemic tumor embolism mimicking gefitinib ('IRESSA')-induced interstitial lung disease in a patient with lung cancer.

Umemura S, Kishino D, Tabata M, Kiura K, Hotta K, Nishii K, Tanimoto Y, Kanehiro A, Notohara K, Ueoka H, Tanimoto M. Umemura S, et al. Among authors: hotta k. Intern Med. 2005 Sep;44(9):979-82. doi: 10.2169/internalmedicine.44.979. Intern Med. 2005. PMID: 16258216 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,494 results

Search Page